SuperworthMoleculin Biotech market cap MBRX
Share price times shares outstanding: what the whole company sells for, since 2016.
- Today, Oct 23, 2026
- $6.3M
- Highest close in our data
- $115.5M
- Apr 2021
Moleculin Biotech is worth $6.3M at the close on Oct 23, 2026, at $6.50 a share.
That is down 57% over the last year and down 92% over five years.
Its highest close in our data was $115.5M in Apr 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $6.3M | $2.1M | $17.4M | −19% |
| 2025 | $7.8M | $2.4M | $22.1M | +57% |
| 2024 | $5M | $5M | $25M | −81% |
| 2023 | $25.6M | $11.6M | $37.2M | −16% |
| 2022 | $30.3M | $26.5M | $57.2M | −43% |
| 2021 | $53.2M | $40.3M | $115.5M | +7% |
| 2020 | $49.8M | $20.3M | $71.9M | +11% |
| 2019 | $44.7M | $23.1M | $57.8M | +60% |
| 2018 | $27.9M | $27.7M | $51M | −29% |
| 2017 | $39.3M | $12.3M | $53.5M | +43% |
| 2016 | $27.5M | $19.9M | $79M | n/a |
Against its peers
Companies in Healthcare nearest Moleculin Biotech's size, closest first, today.
| Company | Market cap |
|---|---|
| MBRXMoleculin Biotech | $6.3M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| Peer median | $47.8M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Moleculin Biotech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.